ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,315 | -4.1% | 10,150 | 0.0% | 0.00% | – |
| Q4 2022 | $22,229 | -25.9% | 10,150 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $30,000 | +3.4% | 10,150 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -46.3% | 10,150 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $54,000 | -40.7% | 10,150 | -16.5% | 0.00% | 0.0% |
| Q4 2021 | $91,000 | -32.6% | 12,150 | -18.2% | 0.00% | -50.0% |
| Q3 2021 | $135,000 | +60.7% | 14,850 | -31.6% | 0.00% | +100.0% |
| Q4 2020 | $84,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
| Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
| Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
| VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
| Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
| EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
| EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
| FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
| Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |